ModernMedicine Resource Center More Topics

Video

Sulcus-to-sulcus suture technique offers solution for silicone oil use in aphakic eyes with iris loss

Retention sutures placed sulcus-to-sulcus in the iris plane are effective for keeping the silicone oil out of the anterior chamber.

Retina Treatments

Consider PDGF treatment prior to anti-VEGF therapyPatients with age-related macular degeneration patients who had received anti-platelet derived growth factor (PDGF) therapy prior to anti-VEGF treatment fared better than those who did not in a pilot study.
Latest concepts in steroid therapy for diabetic macular oedemaSteroids are an important second-line treatment for the treatment of diabetic macular oedema. While side effects remain a concern, modern formulations of intravitreal steroid allow the treatment to be tailored to the individual patient.
Advancing diagnostics and detection of neovascular age-related macular degenerationEarly detection and treatment is essential to preserve vision in patients with age-related macular degeneration. A new device, the ForeseeHome®, uses preferential hyperacuity perimetry for early detection of choroidal neovascularisation before symptoms develop.
Real-world strategies for wet AMDIn many clinical areas, early consultant-led intervention has been shown to improve clinical and patient-reported outcomes and to reduce overall treatment costs. This paper reconfirms this finding in the treatment of wet age-related macular degeneration (wet AMD) and presents data from a publicly funded NHS fast-track (FT) centre in north-west England that aims to see and treat patients within 48 hours of referral.
Outer retinal layer thickness predicts visual acuity in diabetic macular oedemaDiabetes mellitus is a common health problem in developed countries, with diabetic macular oedema (DMO) being a major cause of visual loss. A variety of treatment modalities for DMO are available including laser, steroid and intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents.
Do more anti-VEGF injections lead to better clinical outcomes?The appropriate use of agents that inhibit vascular endothelial growth factor (VEGF) can bring significant improvements to both short-term and long-term visual acuity for patients with neovascular AMD.
How to avoid explosive silicone oil injector separationEnsuring correct alignment between the syringe and the cap during silicone oil injection can prevent complications during vitrectomy, said Jay M. Stewart, MD, (San Francisco) presenting during the Retina Subspecialty Day of the 2015 American Academy of Ophthalmology meeting.
DME trials show advantage to early aflibercept treatment
DME trials show advantage to early aflibercept treatmentPatients treated early with aflibercept (Eylea, Regeneron Pharmaceuticals) for diabetic macular edema (DME) gain more visual acuity than those treated later in the course of the disease.
Innovations fuel sustained drug-delivery methods for AMD
Innovations fuel sustained drug-delivery methods for AMDA variety of newer drug delivery approaches may change how patients with age-related macular degeneration are treated.
Study: Fluocinolone acetonide 0.2 µg/day reduced DR progressionTreatment with fluocinolone acetonide 0.2 µg/day significantly reduced progression to proliferative diabetic retinopathy (PDR) in patients who were part of the FAME trials1,2 and had visual acuity loss due to diabetic macular edema (DME), according to Charles C. Wykoff, MD, PhD.